| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7282 |
| Human Intestinal Absorption | HIA+ | 0.5685 |
| Caco-2 Permeability | Caco2- | 0.6664 |
| P-glycoprotein Substrate | Non-substrate | 0.6539 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9756 |
| Non-inhibitor | 0.9588 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9112 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8427 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8437 |
| CYP450 2D6 Substrate | Non-substrate | 0.8941 |
| CYP450 3A4 Substrate | Non-substrate | 0.7725 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9190 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9435 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9666 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9549 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9408 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9849 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9431 |
| Non-inhibitor | 0.9354 |
| AMES Toxicity | Non AMES toxic | 0.9274 |
| Carcinogens | Non-carcinogens | 0.8328 |
| Fish Toxicity | High FHMT | 0.5000 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9624 |
| Honey Bee Toxicity | High HBT | 0.5899 |
| Biodegradation | Ready biodegradable | 0.9367 |
| Acute Oral Toxicity | III | 0.6609 |
| Carcinogenicity (Three-class) | Non-required | 0.7265 |